ReviewInternational journal of general medicine2026
The Vitamin D-Gut-Brain Axis in Autism Spectrum Disorder: A Bidirectional Crosstalk.
Review in International journal of general medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Autism spectrum disorder (ASD) is a complex neurodevelopmental disorder arising from the interaction of genetic and environmental triggers. In recent years, vitamin D deficiency and gut microbiota dysbiosis have emerged as two pivotal environment-related factors in ASD pathogenesis. Rather than acting independently, these factors jointly participate in the onset and progression of ASD through intricate bidirectional interaction mechanisms. This article presents a narrative review that summarizes the current research progress regarding the association between vitamin D deficiency and gut microbiota dysbiosis in ASD. Mechanistically, vitamin D modulates the gut-brain axis across multiple levels, including gut microbiota composition, intestinal barrier function, intestinal inflammation, bacterial translocation, microbial metabolites, blood-brain barrier integrity and neuroinflammation. In turn, the gut microbiota influences vitamin D metabolism and bioactivity through short-chain fatty acids, establishing a bidirectional vitamin D-gut-brain axis. This axis likely contributes to ASD phenotypes by regulating neuroinflammation, gut-brain crosstalk and neurodevelopmental processes. Notably, most available evidence in this field is derived from preclinical studies, while relevant clinical evidence remains limited. Future studies should focus on dissecting the underlying molecular crosstalk and developing personalized intervention strategies targeting vitamin D status and microbial signatures.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.